134 related articles for article (PubMed ID: 2418910)
21. Effects of chronic ethanol consumption on G proteins in brain areas associated with the nigrostriatal and mesolimbic dopamine systems.
Pellegrino SM; Woods JM; Druse MJ
Alcohol Clin Exp Res; 1993 Dec; 17(6):1247-53. PubMed ID: 8116839
[TBL] [Abstract][Full Text] [Related]
22. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
Elliott PJ; Mason GS; Stephens-Smith M; Hagan RM
Neuropeptides; 1991 Jun; 19(2):119-26. PubMed ID: 1719444
[TBL] [Abstract][Full Text] [Related]
23. Substance K and substance P differentially modulate mesolimbic and mesocortical systems.
Deutch AY; Maggio JE; Bannon MJ; Kalivas PW; Tam SY; Goldstein M; Roth RH
Peptides; 1985; 6 Suppl 2():113-22. PubMed ID: 2417207
[TBL] [Abstract][Full Text] [Related]
24. The effects of thyrotropin releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine systems.
Andrews JS; Sahgal A
Physiol Behav; 1985 Jul; 35(1):93-7. PubMed ID: 2997819
[TBL] [Abstract][Full Text] [Related]
25. Regional expression of c-fos in rat brain following stimulation of the ventral tegmental area.
Cornish JL; van den Buuse M
Neurosci Lett; 1996 Dec; 220(1):17-20. PubMed ID: 8977138
[TBL] [Abstract][Full Text] [Related]
26. Different interactions of prolyl oligopeptidase and neurotensin in dopaminergic function of the rat nigrostriatal and mesolimbic pathways.
Peltonen I; Myöhänen TT; Männistö PT
Neurochem Res; 2012 Sep; 37(9):2033-41. PubMed ID: 22729983
[TBL] [Abstract][Full Text] [Related]
27. Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats.
van den Buuse M
Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):661-8. PubMed ID: 9750953
[TBL] [Abstract][Full Text] [Related]
28. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
Deutch AY; Tam SY; Freeman AS; Bowers MB; Roth RH
Eur J Pharmacol; 1987 Feb; 134(3):257-64. PubMed ID: 3569414
[TBL] [Abstract][Full Text] [Related]
29. Behavioral characterization of intracranial self-stimulation from mesolimbic, mesocortical, nigrostriatal, hypothalamic and extra-hypothalamic sites in the non-inbred CD-1 mouse strain.
Zacharko RM; Kasian M; Irwin J; Zalcman S; LaLonde G; MacNeil G; Anisman H
Behav Brain Res; 1990 Jan; 36(3):251-81. PubMed ID: 2310489
[TBL] [Abstract][Full Text] [Related]
30. Calcitonin gene-related peptide in the ventral tegmental area: selective modulation of prefrontal cortical dopamine metabolism.
Deutch AY; Roth RH
Neurosci Lett; 1987 Feb; 74(2):169-74. PubMed ID: 3554009
[TBL] [Abstract][Full Text] [Related]
31. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
Reid MS; Herrera-Marschitz M; Terenius L; Ungerstedt U
Brain Res; 1990 Sep; 526(2):228-34. PubMed ID: 1701682
[TBL] [Abstract][Full Text] [Related]
32. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Devine DP; Leone P; Pocock D; Wise RA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
[TBL] [Abstract][Full Text] [Related]
33. Intra-median raphe infusions of muscimol and the substance P analogue DiMe-C7 produce hyperactivity: role of serotonin neurons.
Paris JM; Lorens SA
Behav Brain Res; 1987; 26(2-3):139-51. PubMed ID: 2447909
[TBL] [Abstract][Full Text] [Related]
34. Evidence for dose-dependent positively and negatively reinforcing effects of the substance P C-terminal analog DIME-C7.
Hasenöhrl RU; Gerhardt P; Huston JP
Neuropeptides; 1990 Dec; 17(4):205-11. PubMed ID: 1709480
[TBL] [Abstract][Full Text] [Related]
35. Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra.
Deutch AY; Tam SY; Roth RH
Brain Res; 1985 Apr; 333(1):143-6. PubMed ID: 3995282
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
Keeler JR; Charlton CG; Helke CJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
[TBL] [Abstract][Full Text] [Related]
37. Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat.
Nishikawa T; Fage D; Scatton B
Brain Res; 1986 May; 373(1-2):324-36. PubMed ID: 2424555
[TBL] [Abstract][Full Text] [Related]
38. Release of dopamine in the ventral tegmental area of rat.
Fadda F; Melis MR; Argiolas A; Perra G
Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1178-83. PubMed ID: 553533
[TBL] [Abstract][Full Text] [Related]
39. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
40. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat.
Kalivas PW; Duffy P
Biol Psychiatry; 1989 Apr; 25(7):913-28. PubMed ID: 2541803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
